Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.204 EUR | -1.92% |
|
0.00% | +63.78% |
06-28 | EARNINGS AND TRADING: Thruvision loss widens but Polarean loss narrows | AN |
06-28 | Science in Sport Appoints New Finance, Commercial Chiefs | MT |
Valuation
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Capitalization 1 | 52.5 | 47.28 | 91.32 | 23.49 | 21.18 | 33.34 | - | - |
Enterprise Value (EV) 1 | 48.21 | 36.82 | 86.47 | 23.49 | 21.18 | 53.54 | 52.44 | 51.71 |
P/E ratio | - | - | -13.7 x | -1.77 x | - | - | - | - |
Yield | - | - | - | - | - | - | - | - |
Capitalization / Revenue | 1.04 x | 0.94 x | 1.46 x | - | 0.34 x | 0.66 x | 0.58 x | 0.51 x |
EV / Revenue | 0.95 x | 0.73 x | 1.38 x | - | 0.34 x | 1.05 x | 0.9 x | 0.79 x |
EV / EBITDA | -139 x | 33.5 x | 38.7 x | - | 10.6 x | 13.5 x | 9.57 x | 7.79 x |
EV / FCF | -19.7 x | - | -12.9 x | - | - | 485 x | 1,212 x | 1,195 x |
FCF Yield | -5.09% | - | -7.75% | - | - | 0.21% | 0.08% | 0.08% |
Price to Book | - | - | 2.1 x | - | - | - | - | - |
Nbr of stocks (in thousands) | 119,314 | 133,187 | 133,311 | 167,801 | 180,227 | 180,227 | - | - |
Reference price 2 | 0.4400 | 0.3550 | 0.6850 | 0.1400 | 0.1175 | 0.1850 | 0.1850 | 0.1850 |
Announcement Date | 20-03-18 | 21-03-17 | 22-03-29 | 23-06-29 | 24-06-27 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | 50.57 | 50.35 | 62.54 | - | 62.67 | 50.9 | 57.97 | 65.12 |
EBITDA 1 | -0.347 | 1.1 | 2.234 | - | 1.993 | 3.97 | 5.478 | 6.642 |
EBIT 1 | -5.045 | -2.237 | -5.223 | - | -9.733 | -1.085 | 0.1963 | 1.312 |
Operating Margin | -9.98% | -4.44% | -8.35% | - | -15.53% | -2.13% | 0.34% | 2.01% |
Earnings before Tax (EBT) 1 | -5.064 | -2.273 | -5.337 | - | -11.29 | -2.61 | -1.241 | 0.0734 |
Net income | - | - | - | -10.91 | - | - | - | - |
Net margin | - | - | - | - | - | - | - | - |
EPS | - | - | -0.0500 | -0.0790 | - | - | - | - |
Free Cash Flow 1 | -2.453 | - | -6.701 | - | - | 0.1103 | 0.0433 | 0.0433 |
FCF margin | -4.85% | - | -10.71% | - | - | 0.22% | 0.07% | 0.07% |
FCF Conversion (EBITDA) | - | - | - | - | - | 2.78% | 0.79% | 0.65% |
FCF Conversion (Net income) | - | - | - | - | - | - | - | - |
Dividend per Share 2 | - | - | - | - | - | - | - | - |
Announcement Date | 20-03-18 | 21-03-17 | 22-03-29 | 23-06-29 | 24-06-27 | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - | 20.2 | 19.1 | 18.4 |
Net Cash position 1 | 4.29 | 10.5 | 4.85 | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | - | 5.088 x | 3.486 x | 2.766 x |
Free Cash Flow 1 | -2.45 | - | -6.7 | - | - | 0.11 | 0.04 | 0.04 |
ROE (net income / shareholders' equity) | - | - | - | - | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
Assets | - | - | - | - | - | - | - | - |
Book Value Per Share | - | - | 0.3300 | - | - | - | - | - |
Cash Flow per Share | - | - | - | - | - | - | - | - |
Capex | - | - | 6.54 | - | - | - | - | - |
Capex / Sales | - | - | 10.46% | - | - | - | - | - |
Announcement Date | 20-03-18 | 21-03-17 | 22-03-29 | 23-06-29 | 24-06-27 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
![Consensus](/images/consensus_flch.gif)
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+16.57% | 8.36B | |
+3.08% | 7.69B | |
-22.01% | 4.6B | |
-9.60% | 3.58B | |
-19.14% | 3.22B | |
-6.31% | 1.28B | |
-26.93% | 1.11B | |
-7.66% | 887M | |
-16.16% | 856M |
- Stock Market
- Equities
- SIS Stock
- 8D9 Stock
- Financials Science in Sport plc